Natalie Gibson
Nurse Practitioner · Providence, UTNPI 1528419330
Payments from drug & device makers
Across 188 payments — averaging $16.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$222
- Lundbeck LLC$200
- Otsuka America Pharmaceutical, Inc.$115
- Corium, LLC$113
- Grifols USA, LLC$95
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,161100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 78 | $1,261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $222 |
| Lundbeck LLC | 12 | $200 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| Corium, LLC | 6 | $113 |
| Grifols USA, LLC | 5 | $95 |
| Johnson & Johnson | 6 | $92 |
| Amgen | 5 | $86 |
| Idorsia Pharmaceuticals US Inc | 5 | $85 |
| Sunovion Pharmaceuticals Inc. | 4 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Pfizer | 4 | $72 |
| AstraZeneca | 5 | $71 |
| Viiv Healthcare Company | 3 | $64 |
| Alkermes, Inc. | 3 | $51 |
| QOL Medical, LLC | 3 | $49 |
| Novo Nordisk | 3 | $47 |
| Dexcom, Inc. | 2 | $43 |
| Lilly USA, LLC | 3 | $41 |
| Alfasigma USA, Inc. | 2 | $28 |
| Organon | 2 | $27 |
| Ironshore Pharmaceuticals Inc. | 1 | $25 |
| Indivior Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Exact Sciences | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $11 |
How this compares
$3,161 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,875 |
| Rosuvastatin Calcium | 39 | $717 |
| Atomoxetine Hcl | 11 | $594 |
| Omeprazole | 24 | $495 |
| Montelukast Sodium | 20 | $404 |
| Metformin Hcl | 14 | $396 |
| Methylphenidate ErMethylphenidate Hcl | 11 | $380 |
| Fluoxetine Hcl | 18 | $380 |
| Losartan Potassium | 27 | $379 |
| Metformin Hcl ErMetformin Hcl | 24 | $355 |
| Pantoprazole Sodium | 13 | $350 |
| Lisinopril | 14 | $299 |
| Trazodone Hcl | 21 | $277 |
| Atorvastatin Calcium | 43 | $245 |
| Levothyroxine Sodium | 24 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere | $71 | $6,87511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Providence
- David GambleAmerican Fork$836K
- Julia BattenSalt Lake City$223K
- Stacie EganOgden$170K
- Traci AndreasonLehi$161K
- Geoffrey OsmondDraper$62K
- Trenton GraySouth Salt Lake$40K
- Kelsey FurrWest Jordan$21K
- Merin KinikiniSalt Lake City$19K
- Phillip BowmanSalt Lake City$18K
- Lynn LarsenOgden$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.